Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
Really good thoughts posted, thank you!
I am invested in SYN, therefore one should assume I would be biased, HOWEVER - backing a company that has the potential to genuinely make a difference to the material world within which we live is both ethical and rewarding in all respects.
Value is key here and I sincerely hope that the P3 results will support regulatory approval, IMO SNG are deserving of both recognition and reward for all the research, dedication and advancement of human health they have done over the years.
About time the UK government gave due recognition to one of their own shining stars no mater what the final come of the drug trials.
SNG - KEEPING PUSHING!!!!
RM numbers suggest SNG is targeting 100k treatments a month.
Test data so far suggest this treatment may be of value in patients with moderate to severe breathing difficulties, most likely hospital bound patients.
UK currently has ~1000 patients in UK, means for sure bulk demand has to come from other countries who can justify the expense of SNG treatment (obviously subjective to further P3 data and regulatory approval).
As vaccines are rolled out globally, some data suggest we may reach 60% by 2023. Goal being herd immunity to significantly reduce future case numbers ?
Indicates being that we are most likely in the peak of this pandemic? from here hospitalised numbers are likely to decline?
Is 100k monthly treatments for SNG realistic?
This treatment is nothing new, its been around for a number of years and thus far failed to achieve meaningful numbers?
Is SNG's gain more likely form the academia world that commercial?
SYN past performance would most likely deter most investors, we need to take a position based on the P2 and P3 data?
P2 data reflects the position of SNG potentially having a therapeutic that gives a positive effect in breathless patients hospital bound. Expecting P3 to back this up, this being the case SNG should have a therapeutic that can be deployed in hospital bound cases.
This all tends to tie up with RM body language in his presentations over the last 12 months which indicate SNG clearly know where their drug adds valve. SNG are taking full advantage of external funding to get through the data gathering phases.
Why do you think 6 month gamble?
SNG started P3 with 610 sadly hospitalised people, results expected by end of Q2. Based on todays results, surely we can expect further positive results.
My take on today is that SNG is on course to offer a therapeutic that can save lives.
As much as i would love much lower dips, just have to settle for them as they come along.
My view of RR is that its one of the most prominent, capable and advanced engineering companies in the world and a true market leader. These dips are real opportunities for medium/long term investments!
Fitch down grade states CINE may run out by the end of this year?
Jobs will come back as soon as CINE opens back up gain under new owner WITHOUT HUGE debt?
Goes bankrupt, vultures move in, keeps on going. No impact on jobs, just Shareholders get shafted?
No shrewd business would take this on until its been declared insolvent, debt needs to be written off or heavily reduced! then its a bargain!!
"FTI Consulting has been drafted in by a syndicate of lenders to the stricken cinema operator"
Another nail with lenders being called in!!
@ Laidback, I understand your thoughts, however I'm assuming the probability of achieving 2021 sales at 2019 levels is very low? life will take time to recover from the pandemic, during this time debt will continue to pile up
Only challenge I see with CINE is how it will manage the increasing debt burden, this is likely to increase for the next couple of years.
The underlying Cinema business is very profitable minus the DEBT - I expect CINE to restructure its debt burden, if not it risks becoming a ZOMBIE business wiping out its share holders in the process.
Just to be clear, I am a believer in CINEMAS!
Any one have any thoughts on debt level additions come the end of 2021?
2020 close out at 3-3.5 BILLION
2021 close out at 1-2.5 BILLION
Total 2020+2021 4-6 BILLION additional debt load?